Main > NEUROLOGY. > ADHD > Treatment > LisDexAmfetamine DiMesylate > Co.: USA. S. (Brand Cap./Patents)
Co.: USA. S. (Brand Cap./Patents)'s subsections
Approved Strengths >
Company
FDA Approval Date: 02.23.2007
Marketing: USA
Patent>DisClosure
Patent>Total USA No.: 2
Patent>UpDate: 07.03.07
Patent>USA Expiration: 06.01.2024
Pediatrics
ProDrug Stimulant
TradeMark
UpDate: 01.03.08
Web-Site (USA)
Co.: USA. S. (Brand Cap./Patents)'s products
This section has no products